Clinical trial

Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing…

NCT00036881 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00036881
Title Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Official title Phase III Double-Blind, Placebo-Controlled Randomized Comparison Of Zinc Sulfate Versus Placebo For The Prevention Of Altered Taste In Patients With Head And Neck Cancer During Radiation
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Dysgeusia, Head and Neck Cancer, Oral Complications, Radiation Toxicity
Intervention type Dietary Supplement, Other
Interventions zinc sulfate, placebo
Enrollment 173
Start date May 1, 2002
Primary completion Apr 1, 2007
Completion Jun 1, 2007
First posted Jan 27, 2003
Last update posted Jul 14, 2016

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies